ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Hollings Cancer Center at MUSC Wins NCI Designation

March 6, 2009

Pat Barr, Early NBCC Activist, Dead.

June 27, 2003

In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel

March 25, 1988

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002